Cargando…
Interactions between FGFR2 and RSK2—implications for breast cancer prognosis
We have previously demonstrated that fibroblast growth factor receptor 2 (FGFR2) activates ribosomal s6 kinase 2 (RSK2) in mammary epithelial cells and that this pathway promotes in vitro cell growth and migration. Potential clinical significance of FGFR2 and RSK2 association has never been investig...
Autores principales: | Czaplinska, Dominika, Mieczkowski, Kamil, Supernat, Anna, Skladanowski, Andrzej C., Kordek, Radzislaw, Biernat, Wojciech, Zaczek, Anna J., Romanska, Hanna M., Sadej, Rafal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097089/ https://www.ncbi.nlm.nih.gov/pubmed/27476168 http://dx.doi.org/10.1007/s13277-016-5266-9 |
Ejemplares similares
-
FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
por: Turczyk, Lukasz, et al.
Publicado: (2017) -
Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells
por: Piasecka, Dominika, et al.
Publicado: (2016) -
FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
por: Mieczkowski, Kamil, et al.
Publicado: (2022) -
Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma
por: Braun, Marcin, et al.
Publicado: (2020) -
A ‘Real-Life’ Experience on Automated Digital Image Analysis of FGFR2 Immunohistochemistry in Breast Cancer
por: Braun, Marcin, et al.
Publicado: (2020)